Live Breaking News & Updates on Verrica pharmaceuticals stock down

Stay informed with the latest breaking news from Verrica pharmaceuticals stock down on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Verrica pharmaceuticals stock down and stay connected to the pulse of your community

Verrica Pharmaceuticals (NASDAQ:VRCA) Receives Buy Rating from Needham & Company LLC

Verrica Pharmaceuticals (NASDAQ:VRCA) Receives Buy Rating from Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , American , News-ratings-for-verrica-pharmaceuticals-daily , Virtu-financial , Verrica-pharmaceuticals-stock-down , Jump-financial , Perceptive-advisors-llc , Verrica-pharmaceuticals , Jefferies-financial-group , Verrica-pharmaceuticals-inc , Institutional-trading-of-verrica-pharmaceuticals

Verrica Pharmaceuticals (NASDAQ:VRCA) Stock Price Down 3.5%

Shares of Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) dropped 3.5% during trading on Wednesday . The company traded as low as $5.10 and last traded at $5.17. Approximately 122,863 shares traded hands during mid-day trading, a decline of 37% from the average daily volume of 195,945 shares. The stock had previously closed at […]

United-states , American , Joe-bonaccorso , American-international-group-inc , Vontobel-holding-ltd , Virtu-financial , Needham-company , Nasdaq , Verrica-pharmaceuticals-inc , Jefferies-financial-group , Verrica-pharmaceuticals-stock-down , Financial-inc

Jefferies Financial Group Reiterates Buy Rating for Verrica Pharmaceuticals (NASDAQ:VRCA)

Jefferies Financial Group reaffirmed their buy rating on shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) in a report issued on Friday morning, Benzinga reports. Jefferies Financial Group currently has a $10.00 price objective on the stock. Several other equities analysts have also recently issued reports on the company. Needham & Company LLC reduced their […]

Canada , California , United-states , Joe-bonaccorso , Tower-research-capital , Verrica-pharmaceuticals-company-profile , Cubist-systematic-strategies , Verrica-pharmaceuticals-stock-down , Institutional-investors-weigh-in-on-verrica-pharmaceuticals , Securities-exchange-commission , Needham-company , Jefferies-financial-group

Verrica Pharmaceuticals (NASDAQ:VRCA) Stock Rating Upgraded by Needham & Company LLC

Verrica Pharmaceuticals (NASDAQ:VRCA) Stock Rating Upgraded by Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Ted-white , Christopherg-hayes , Institutional-trading-of-verrica-pharmaceuticals , Needham-company , Dimensional-fund-advisors , Verrica-pharmaceuticals , News-ratings-for-verrica-pharmaceuticals-daily , Verrica-pharmaceuticals-stock-down , Verrica-pharmaceuticals-company-profile , Verrica-pharmaceuticals-inc